130 related articles for article (PubMed ID: 34752732)
1. Fasciola hepatica fatty acid binding protein (Fh12) induces apoptosis and tolerogenic properties in murine bone marrow derived dendritic cells.
Ruiz-Jiménez C; Celias D; Valdés B; Ramos-Pérez WD; Cervi L; Espino AM
Exp Parasitol; 2021 Dec; 231():108174. PubMed ID: 34752732
[TBL] [Abstract][Full Text] [Related]
2. Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by lipopolysaccharide in vitro and in vivo.
Martin I; Cabán-Hernández K; Figueroa-Santiago O; Espino AM
J Immunol; 2015 Apr; 194(8):3924-36. PubMed ID: 25780044
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands.
Ramos-Benítez MJ; Ruiz-Jiménez C; Aguayo V; Espino AM
Sci Rep; 2017 Jul; 7(1):5455. PubMed ID: 28710478
[TBL] [Abstract][Full Text] [Related]
4. Fasciola hepatica fatty acid binding protein induces the alternative activation of human macrophages.
Figueroa-Santiago O; Espino AM
Infect Immun; 2014 Dec; 82(12):5005-12. PubMed ID: 25225247
[TBL] [Abstract][Full Text] [Related]
5. The Fasciola hepatica tegumental antigen suppresses dendritic cell maturation and function.
Hamilton CM; Dowling DJ; Loscher CE; Morphew RM; Brophy PM; O'Neill SM
Infect Immun; 2009 Jun; 77(6):2488-98. PubMed ID: 19332532
[TBL] [Abstract][Full Text] [Related]
6. Purification of Native Fasciola hepatica Fatty Acid-Binding Protein and Induction of Alternative Activation of Human Macrophages.
Figueroa-Santiago O; Espino A
Methods Mol Biol; 2020; 2137():149-169. PubMed ID: 32399927
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin L3 From
Celias DP; Corvo I; Silvane L; Tort JF; Chiapello LS; Fresno M; Arranz A; Motrán CC; Cervi L
Front Immunol; 2019; 10():552. PubMed ID: 30967874
[TBL] [Abstract][Full Text] [Related]
8. A fatty acid binding protein from Fasciola hepatica induced protection in C57/BL mice from challenge infection with Schistosoma bovis.
Abán JL; Ramajo V; Arellano JL; Oleaga A; Hillyer GV; Muro A
Vet Parasitol; 1999 Jun; 83(2):107-21. PubMed ID: 10392967
[TBL] [Abstract][Full Text] [Related]
9.
Zawistowska-Deniziak A; Lambooij JM; Kalinowska A; Patente TA; Łapiński M; van der Zande HJP; Basałaj K; de Korne CM; Chayé MAM; Gasan TA; Norbury LJ; Giera M; Zaldumbide A; Smits HH; Guigas B
Front Immunol; 2022; 13():884663. PubMed ID: 35720355
[TBL] [Abstract][Full Text] [Related]
10. The fatty acid-binding protein (FABP) decreases the clinical signs and modulates immune responses in a mouse model of experimental autoimmune encephalomyelitis (EAE).
Hajizadeh M; Saboor-Yaraghi AA; Meamar AR; Khoshmirsafa M; Razmjou E; Sadeghipour A; Bagheri Y; Sadeghi F; Jalallou N; Kazemi MH; Salari AA; Falak R
Int Immunopharmacol; 2021 Jul; 96():107756. PubMed ID: 33993100
[TBL] [Abstract][Full Text] [Related]
11. Isolation and immunological characterization of fatty acid binding protein isoforms from Fasciola hepatica.
Espino AM; Rodríguez Medina JR; Hillyer GV
J Parasitol; 2001 Oct; 87(5):1028-33. PubMed ID: 11695360
[TBL] [Abstract][Full Text] [Related]
12. A mucin-like peptide from Fasciola hepatica instructs dendritic cells with parasite specific Th1-polarizing activity.
Noya V; Brossard N; Rodríguez E; Dergan-Dylon LS; Carmona C; Rabinovich GA; Freire T
Sci Rep; 2017 Jan; 7():40615. PubMed ID: 28079156
[TBL] [Abstract][Full Text] [Related]
13. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
[TBL] [Abstract][Full Text] [Related]
14. Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses.
Dowling DJ; Hamilton CM; Donnelly S; La Course J; Brophy PM; Dalton J; O'Neill SM
Infect Immun; 2010 Feb; 78(2):793-801. PubMed ID: 19917714
[TBL] [Abstract][Full Text] [Related]
15. Fasciola hepatica tegumental coat antigen suppresses MAPK signalling in dendritic cells and up-regulates the expression of SOCS3.
Vukman KV; Adams PN; O'Neill SM
Parasite Immunol; 2013 Jul; 35(7-8):234-8. PubMed ID: 23495757
[TBL] [Abstract][Full Text] [Related]
16. Fasciola hepatica Kunitz type molecule decreases dendritic cell activation and their ability to induce inflammatory responses.
Falcón CR; Masih D; Gatti G; Sanchez MC; Motrán CC; Cervi L
PLoS One; 2014; 9(12):e114505. PubMed ID: 25486609
[TBL] [Abstract][Full Text] [Related]
17. Glycans from Fasciola hepatica Modulate the Host Immune Response and TLR-Induced Maturation of Dendritic Cells.
Rodríguez E; Noya V; Cervi L; Chiribao ML; Brossard N; Chiale C; Carmona C; Giacomini C; Freire T
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004234. PubMed ID: 26720149
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
[TBL] [Abstract][Full Text] [Related]
19. Fasciola hepatica tegumental antigens indirectly induce an M2 macrophage-like phenotype in vivo.
Adams PN; Aldridge A; Vukman KV; Donnelly S; O'Neill SM
Parasite Immunol; 2014 Oct; 36(10):531-9. PubMed ID: 25039932
[TBL] [Abstract][Full Text] [Related]
20. Paeoniflorin inhibits the maturation and immunostimulatory function of allergen-induced murine dendritic cells.
Shi D; Ma A; Zheng H; Huo G; Yan H; Fu H; Qiu Y; Liu W
Int Immunopharmacol; 2014 Apr; 19(2):221-32. PubMed ID: 24534772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
